Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yincan Tongluo
- Development stage
- Unknown
- Lead developer
- Tianshan Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yincan Tongluo (银参通络胶囊) is an approved oral Traditional Chinese Medicine (TCM) capsule developed by Tianshan Pharmaceuticals (also known as Tiansheng Pharmaceutical Group) for the treatment of cardiovascular and cerebrovascular diseases. It is a nationally exclusive product in China, formulated as a solid TCM preparation. While the specific herbal composition and molecular targets are not detailed in public pipeline summaries, the drug is intended to improve blood circulation and address vascular conditions associated with the heart and brain. It is administered orally in capsule form and is part of the company's core portfolio of exclusive TCM products.
- Brand names
- Yincan Tongluo
- Other names
- 银参通络胶囊Yincan Tongluo Jiaonang
02
Targets
EGFR (Epidermal growth factor receptor)JUN (Transcription factor Jun)MAPK14 (p38 mitogen-activated protein kinase alpha)MAPK3 (Mitogen-activated protein kinase 1)PTPN11 (Tyrosine-protein phosphatase non-receptor type 11)RELA (Nuclear Factor Kappa B Subunit p65)SRC (Proto-oncogene tyrosine-protein kinase Src)STAT1 (Signal transducer and activator of transcription protein 1)STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on Yincan Tongluo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yincan Tongluo.